FDA Warns Matrixx Over Zicam Marketing
The U.S. Food and Drug Administration revealed Tuesday that it had warned Matrixx Initiatives Inc. over the company's marketing of two Zicam products as cold remedies without the agency's approval....To view the full article, register now.
Already a subscriber? Click here to view full article